Skip to main content
. 2024 Dec 30;13(1):62. doi: 10.3390/biomedicines13010062
PDAC Pancreatic ductal adenocarcinoma
CA19-9 Carbohydrate antigen 19-9
FE-1 Fecal elastase-1
NCCN National Comprehensive Cancer Network
OS Overall survival
RFS Recurrence-free survival
ELISA Enzyme-linked immunosorbent assay
ROC Receiver operating characteristic
AUC Area under the curve
HR Hazard ratio